These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27410258)

  • 21. Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo.
    Davies LP; Baird-Lambert J; Marwood JF
    Biochem Pharmacol; 1986 Sep; 35(18):3021-9. PubMed ID: 3019353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Adenosine Kinase Inhibitor in Adenosine Augmentation Therapy for Epilepsy: A Potential Novel Drug for Epilepsy.
    Wang X; Li T
    Curr Drug Targets; 2020; 21(3):252-257. PubMed ID: 31633474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.
    Boyer SH; Ugarkar BG; Solbach J; Kopcho J; Matelich MC; Ollis K; Gomez-Galeno JE; Mendonca R; Tsuchiya M; Nagahisa A; Nakane M; Wiesner JB; Erion MD
    J Med Chem; 2005 Oct; 48(20):6430-41. PubMed ID: 16190769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridopyrimidine analogues as novel adenosine kinase inhibitors.
    Zheng GZ; Lee C; Pratt JK; Perner RJ; Jiang MQ; Gomtsyan A; Matulenko MA; Mao Y; Koenig JR; Kim KH; Muchmore S; Yu H; Kohlhaas K; Alexander KM; McGaraughty S; Chu KL; Wismer CT; Mikusa J; Jarvis MF; Marsh K; Kowaluk EA; Bhagwat SS; Stewart AO
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2071-4. PubMed ID: 11514141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity.
    Cao W; Yuan Y; Liu X; Li Q; An X; Huang Z; Wu L; Zhang B; Zhang A; Xing C
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F107-F115. PubMed ID: 30995110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes.
    Muchmore SW; Smith RA; Stewart AO; Cowart MD; Gomtsyan A; Matulenko MA; Yu H; Severin JM; Bhagwat SS; Lee CH; Kowaluk EA; Jarvis MF; Jakob CL
    J Med Chem; 2006 Nov; 49(23):6726-31. PubMed ID: 17154503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding.
    Schumacher MA; Scott DM; Mathews II; Ealick SE; Roos DS; Ullman B; Brennan RG
    J Mol Biol; 2000 Feb; 296(2):549-67. PubMed ID: 10669608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.
    Golembiowska K; White TD; Sawynok J
    Eur J Pharmacol; 1996 Jun; 307(2):157-62. PubMed ID: 8832217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase.
    Davies LP; Jamieson DD; Baird-Lambert JA; Kazlauskas R
    Biochem Pharmacol; 1984 Feb; 33(3):347-55. PubMed ID: 6322800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase.
    Kim YA; Sharon A; Chu CK; Rais RH; Al Safarjalani ON; Naguib FN; el Kouni MH
    J Med Chem; 2008 Jul; 51(13):3934-45. PubMed ID: 18563892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.
    Brogi S; Ramunno A; Savi L; Chemi G; Alfano G; Pecorelli A; Pambianchi E; Galatello P; Compagnoni G; Focher F; Biamonti G; Valacchi G; Butini S; Gemma S; Campiani G; Brindisi M
    Eur J Med Chem; 2017 Sep; 138():438-457. PubMed ID: 28689095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
    Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
    J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of Chinese hamster cells mutants affected in adenosine kinase and showing novel genetic and biochemical characteristics.
    Cui XA; Agarwal T; Singh B; Gupta RS
    BMC Biochem; 2011 May; 12():22. PubMed ID: 21586167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
    Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
    J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the synthesis and PKA-I binding activities of 5-alkynyl tubercidin analogues.
    Zhang L; Zhang Y; Li X; Zhang L
    Bioorg Med Chem; 2002 Apr; 10(4):907-12. PubMed ID: 11836097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.
    Bookser BC; Matelich MC; Ollis K; Ugarkar BG
    J Med Chem; 2005 May; 48(9):3389-99. PubMed ID: 15857145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
    Lynch JJ; Jarvis MF; Kowaluk EA
    Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine kinase: exploitation for therapeutic gain.
    Boison D
    Pharmacol Rev; 2013 Jul; 65(3):906-43. PubMed ID: 23592612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds. Role of adenylate deaminase.
    Bennett LL; Brockman RW; Allan PW; Rose LM; Shaddix SC
    Biochem Pharmacol; 1988 Apr; 37(7):1233-44. PubMed ID: 3355597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine dysfunction in epilepsy.
    Boison D
    Glia; 2012 Aug; 60(8):1234-43. PubMed ID: 22700220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.